Stock 543520 GLOBAL LONGLIFE HOSPITAL AND RESEARCH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Global Longlife Hospital and Research Limited

Equities

543520

INE0J2K01014

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 11:00:55 25/06/2024 BST 		5-day change 1st Jan Change
33.88 INR -1.51% Intraday chart for Global Longlife Hospital and Research Limited -1.80% -20.75%
2023 Global Longlife Hospital and Research Limited Announces Appointment of Tanvi Solanki as Company Secretary CI
2023 Global Longlife Hospital and Research Limited Announces Resignation of Deepak Sharma as Company Secretary CI

Valuation

Fiscal Period: März 2023
Capitalization 1 470.2
Enterprise Value (EV) 1 525.9
P/E ratio 25 x
Yield -
Capitalization / Revenue 2 x
EV / Revenue 2.24 x
EV / EBITDA 12.9 x
EV / FCF -2,217,872 x
FCF Yield -0%
Price to Book 0.73 x
Nbr of stocks (in thousands) 10,500
Reference price 2 44.78
Announcement Date 01/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023
Net sales 1 345.4 335.4 327 328.2 235.1
EBITDA 1 61.79 27.96 54.89 83.19 40.71
EBIT 1 46.26 12.62 41.84 71.75 29.05
Operating Margin 13.39% 3.76% 12.8% 21.87% 12.36%
Earnings before Tax (EBT) 1 26.88 -10.64 18.16 57.1 27.08
Net income 1 13.65 -8.624 10.35 35.74 18.28
Net margin 3.95% -2.57% 3.17% 10.89% 7.77%
EPS 2 2.532 -1.232 1.479 5.106 1.790
Free Cash Flow - 48.47 56.78 62.71 -237.1
FCF margin - 14.45% 17.36% 19.11% -100.88%
FCF Conversion (EBITDA) - 173.38% 103.45% 75.39% -
FCF Conversion (Net income) - - 548.43% 175.48% -
Dividend per Share - - - - -
Announcement Date 30/11/21 30/11/21 30/11/21 01/09/22 01/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2019 2020 2021 2022 2023
Net Debt 1 265 220 160 83.7 55.7
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 4.293 x 7.878 x 2.92 x 1.007 x 1.369 x
Free Cash Flow - 48.5 56.8 62.7 -237
ROE (net income / shareholders' equity) - -7.23% 8.62% 23.3% 4.5%
ROA (Net income/ Total Assets) - 1.85% 6.72% 12.7% 3.3%
Assets 1 - -465.8 154 281.9 553.2
Book Value Per Share 2 22.90 16.40 17.90 24.20 61.20
Cash Flow per Share 2 0.8900 1.840 1.160 0.3100 3.430
Capex 1 3.99 1.06 0.42 4.75 20
Capex / Sales 1.15% 0.32% 0.13% 1.45% 8.53%
Announcement Date 30/11/21 30/11/21 30/11/21 01/09/22 01/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
GLOBAL LONGLIFE HOSPITAL AND RESEARCH LIMITED Stock Global Longlife Hospital and Research Limited
-20.75% 4.26M
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-32.30% 13.37B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.75B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-3.60% 11.57B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+7.59% 10.85B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+26.92% 8.55B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-11.44% 7.24B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+7.27% 6.84B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+8.77% 6.5B
CONCORD HEALTHCARE GROUP CO., LTD. Stock Concord Healthcare Group Co., Ltd.
0.00% 4.4B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. 543520 Stock
  4. Financials Global Longlife Hospital and Research Limited